Friendly” labels on the packaging are becoming more common in U.S. supermarkets as a growing number of Americans try obesity ...

Discontinuing obesity medicines often means the weight comes back and people lose the cardiovascular and metabolic benefits ...

MEDVi, a telehealth platform serving more than 100,000 patients, today announced an expanded physician-led program ...

If you’re using a GLP-1 for weight loss or blood sugar control, you may want to avoid certain supplements. Here’s what ...

SAN FRANCISCO -- Patients with colon cancer and comorbid obesity treated with GLP-1 receptor agonists had lower mortality and ...

Concerns about GLP-1 drugs indicated for weight loss were first raised after the FDA's Adverse Event Reporting System ...

Since we know that eating less food often means getting fewer nutrients, a high-quality multivitamin acts as an insurance ...

The FDA is requesting that manufacturers of three GLP-1 receptor agonists remove information on risk for suicidal ideation ...

After a period of diversification, Novo Nordisk is returning to its roots by focusing on the 2 billion people with diabetes, ...

Oprah Winfrey says she had one big main side effect from taking a GLP-1 weight-loss drug. The most common problems for ...

Oral weight-loss drugs could account for a third or more of the overall GLP-1 market by 2030, a Novo Nordisk executive said ...

Novo Nordisk CEO Mike Doustdar said on Monday as many as 1.5 million patients in the U.S. may be using compounded versions of ...